Announcement under Regulation 30 (LODR)-Newspaper Publication
we are enclosing herewith Copies of Newspaper Advertisement of the Notice Published on May 23, 2018 in 'The Economic Times, Ahmedabad Edition' (Gujarati & English) in respect of Board Meeting of the Company to be held on May 30, 2018, inter alia, to Consider and Approve the Audited Consolidated and Standalone Financial Results of the Company for the Quarter and Year Ended on March 31, 2018. Board to consider Dividend
Lincoln Pharmaceuticals Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2018, inter alia, to consider the Following Businesses:1. Approval and Adoption of Audited Consolidated and Standalone Financial Results of the Company for the Quarter and Year Ended on March 31, 2018.... Compliance Certificate From PCS For Transfer/Transmission/Transposition For The Half Year Ended March 31, 2018
Compliance Certificate from PCS for Transfer/Transmission/Transposition for the Half Year Ended March 31, 2018 Shareholding for the Period Ended March 31, 2018
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here Compliance Certificate As Per Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Period Ended March 31, 2018.
Compliance Certificate as per Regulation 7(3) Of SEBI (LODR) Regulations, 2015 for the Period Ended March 31, 2018. Compliance Certificate As Per Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Period Ended March 31, 2018.
Compliance Certificate as per Regulation 7(3) Of SEBI (LODR) Regulations, 2015 for the Period Ended March 31, 2018. Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- BHAVIK P. PARIKHDesignation :- Company Secretary and Compliance Officer Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shardaben Gulabdas Patel Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yogeshkumar Ishwerlal Patel Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 For Appointment Of Director
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company, at its meeting held on Tuesday, March 27, 2018, has appointed Mr. Saurin J. Parikh as an Additional Director (categorised as an Independent Director) on the Board of the Company.